
|Articles|August 1, 2022
What's New on Dermatology Times: August 1-5
Author(s)Dermatology Times Staff
Click to see a preview of what to expect this week.
Advertisement
Some of the content the staff at Dermatology Times® will be publishing this week includes:
Content about new treatment methods for cutaneous T-cell lymphoma;
Coverage on the AbbVie webinar, The Science of Skin;
Data from a clinical trial examining atopic dermatitis and sleep quality;
Exclusive video interviews with KOLs;
Plus more!
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Grants Priority Review to Zasocitinib for Moderate-to-Severe Plaque Psoriasis
2
FDA Accepts Bezuclastinib NDA for Advanced Systemic Mastocytosis
3
Genetic Study Links Higher BMI to Perceived Facial Aging, but Causality Remains Unproven
4
Defining AD Disease Flares vs Drug Effects: A Comparative Analysis of Phase 3 Systemic Therapy Trials
5






